The importance of ePRO to support NASH/NAFLD unmet clinical research and medical needs
NonAlcoholic SteatoHepatitis (NASH), now called Metabolic Dysfunction-Associated SteatoHepatitis (MASH), affects almost 115 million adults globally
Insights from Kayentis clients: why you should choose Kayentis as your eCOA & DCT provider
Last update : 9 March 2023